Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of SFN (sulforaphane) to preparation of medicine for treating leukemia

A technology of sulforaphane and leukemia, which is applied in the field of application of sulforaphane in the treatment of leukemia drugs, and can solve the problems of less reports on the role and mechanism of hematopoietic tumor cells

Inactive Publication Date: 2017-08-04
XINXIANG MEDICAL UNIV +1
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are few reports on the effect and mechanism of SFN on hematopoietic tumor cells.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of SFN (sulforaphane) to preparation of medicine for treating leukemia
  • Application of SFN (sulforaphane) to preparation of medicine for treating leukemia
  • Application of SFN (sulforaphane) to preparation of medicine for treating leukemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0017] 1. Experimental materials

[0018] Sulforaphane (batch number 28911701) was purchased from LKT Laboratories, USA, with a purity of 98%. 1640 culture medium and fetal bovine serum are products of Gibco Company in the United States. CCK-8 kit was purchased from Dojindo Company in Japan, Annexin-V / PI apoptosis detection reagent (BD Company, USA, batch number 5121706), RNA extraction kit, reverse transcription kit, PCR reagent 2×Taq PCRMaster Mix, DNA Marker All were purchased from Shanghai Tiangen, agarose (Biowest, Spain), primers were synthesized by Shanghai Bioengineering Company, rabbit anti-human Bax mAb, rabbit anti-human Bcl-2 mAb, rabbit anti-human Caspase-3 mAb were produced by American Abcam Company, anti-human Human GAPDH pAb and HRP-goat anti-rabbit pAb were provided by Century Kangwei Company. The flow cytometer (FACSCaibur type) is produced by BD Company in the United States, the MK3 microplate reader and ND2000 ultra-micro spectrophotometer are produced by...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of SFN (sulforaphane) to preparation of medicine for treating leukemia, and belongs to the technical field of novel purpose of the SFN. The application is characterized in that according to the application of the SFN to the preparation of the medicine for treating the leukemia, the SFN promotes the leukemia apoptosis through raising Bax genes and Caspase-3 genes and reducing Bcl-2 genes for further inhibiting the multiplication of leukemia cells. The influence of the SFN on the acute leukemia cell KG1a and K562 apoptosis is systematically discussed for the first time; a result proves that the SFN can promote the acute leukemia apoptosis through regulating and controlling the Bax genes, the Bcl-2 genes and the Caspase-3 genes; the result belongs to the theoretical breakthrough and has the potential clinic application significance; a fire-new thought and potential treatment path is provided for leukemia treatment.

Description

technical field [0001] The invention relates to the technical field of new uses of sulforaphane, in particular to the application of sulforaphane in medicines for treating leukemia. Background technique [0002] Sulforaphane (SFN) is an isothiocyanate substance present in broccoli and other cruciferous vegetables, which has anti-proliferative ability. It has inhibitory effect on the growth of malignant tumor cells and is a new type of anti-cancer ingredient. However, the effect and mechanism of SFN on hematopoietic tumor cells are less reported. [0003] Uncontrolled cell cycle is one of the important causes of malignant proliferative diseases. Acute leukemia is a malignant clonal disease of hematopoietic stem cells. Leukemia cells proliferate massively in bone marrow and other hematopoietic tissues due to uncontrolled proliferation, impaired differentiation, and blocked apoptosis, and infiltrate other tissues and organs, while normal hematopoiesis is inhibited. The Bcl-2...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/145A61P35/02
CPCA61K31/145
Inventor 王凡平王明永王闪闪康丽霞乔瑞娟李克君王艳于海川牛志国
Owner XINXIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com